(Q33417353)

26 July 2017

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy (English)

1 reference

26 July 2017

1 reference

1 reference

1 reference

Daniel J Tenney

1

1 reference

26 July 2017

Ronald E Rose

2

1 reference

26 July 2017

Carl J Baldick

3

1 reference

26 July 2017

Kevin A Pokornowski

4

1 reference

26 July 2017

Betsy J Eggers

5

1 reference

26 July 2017

Jie Fang

6

1 reference

26 July 2017

Michael J Wichroski

7

1 reference

26 July 2017

Dong Xu

8

1 reference

26 July 2017

Joanna Yang

9

1 reference

26 July 2017

Richard B Wilber

10

1 reference

26 July 2017

Richard J Colonno

11

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 May 2009

1 reference

26 July 2017

1 reference

26 July 2017

49

1 reference

26 July 2017

1503-1514

1 reference

26 July 2017

5

1 reference

Hepatitis B virus infection: epidemiology and vaccination

26 July 2017

1 reference

Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach

21 January 2018

1 reference

21 January 2018

1 reference

The impact of drug resistance on the effectiveness of chemotherapy for chronic hepatitis B.

21 January 2018

1 reference

Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B.

21 January 2018

1 reference

Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine

21 January 2018

1 reference

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

21 January 2018

1 reference

Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response

21 January 2018

1 reference

Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance

21 January 2018

1 reference

Two-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions present

21 January 2018

1 reference

In vitro susceptibilities of wild-type or drug-resistant hepatitis B virus to (-)-beta-D-2,6-diaminopurine dioxolane and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil

21 January 2018

1 reference

Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC).

21 January 2018

1 reference

Inhibition of hepatitis B virus polymerase by entecavir

21 January 2018

1 reference

Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy.

21 January 2018

1 reference

Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil

21 January 2018

1 reference

Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation.

21 January 2018

1 reference

Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure

21 January 2018

1 reference

A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patients.

21 January 2018

1 reference

Entecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis B

21 January 2018

1 reference

Emergence of a novel lamivudine-resistant hepatitis B virus variant with a substitution outside the YMDD motif.

21 January 2018

1 reference

Antiviral-resistant hepatitis B virus: can we prevent this monster from growing?

21 January 2018

1 reference

Selection of a virus strain resistant to entecavir in a nucleoside-naive patient with hepatitis B of genotype H.

21 January 2018

1 reference

Stepwise process for the development of entecavir resistance in a chronic hepatitis B virus infected patient

21 January 2018

1 reference

Evolution of multi-drug resistant hepatitis B virus during sequential therapy

21 January 2018

1 reference

Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir.

21 January 2018

1 reference

In vitro activity of 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine against multidrug-resistant hepatitis B virus mutants

21 January 2018

1 reference

Progress in the treatment of chronic hepatitis B: long-term experience with adefovir dipivoxil

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Entecavir resistance is rare in nucleoside naïve patients with hepatitis B

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.22841

1 reference

26 July 2017

1 reference